-
1 Comment
Solasto Corporation is currently in a long term downtrend where the price is trading 2.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Solasto Corporation's total revenue rose by 13.9% to $28B since the same quarter in the previous year.
Its net income has increased by 10.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 33.0% to $3B since the same quarter in the previous year.
Based on the above factors, Solasto Corporation gets an overall score of 4/5.
Exchange | TSE |
---|---|
Sector | Healthcare |
ISIN | JP3436250009 |
CurrencyCode | JPY |
Industry | Medical Care Facilities |
Beta | 0.71 |
---|---|
Market Cap | 41B |
PE Ratio | 34.38 |
Target Price | 557.5 |
Dividend Yield | 4.3% |
Solasto Corporation provides medical outsourcing services to medical institutions in Japan. The company's medical outsourcing services, including medical office work, temporary staffing, and hospital management support. It offers smart hospital, nursing care, and childcare services, as well as engages in the education business. The company was formerly known as N.I.C Corporation. Solasto Corporation was founded in 1965 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6197.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025